TYVASO SMI
"TYVASO SMI" is a word mark owned by United Therapeutics Corporation, filed at the USPTO on October 23, 2026. It is under examination and covers classes 5 and 10.
- Status
- Under examination
- Since October 23, 2026
- Filed
- October 23, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50178526
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 2 classes
Who owns TYVASO SMI
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
United Therapeutics Corporation
UTHR · Silver Spring, United States
Representative
Norm J. Rich
Foley & Lardner LLP
What the mark covers
The products and services TYVASO SMI is filed for, grouped by Nice class.
Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers for medical purposes, sold filled with pharmaceutical preparations for treating pulmonary fibrosis and other pulmonary conditions
Chambers for inhalers; Inhalers for medical purposes, sold empty; Medical apparatus for facilitating the inhalation of pharmaceutical preparations
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application entered
About TYVASO SMI
Who owns the trademark "TYVASO SMI"?
The USPTO trademark "TYVASO SMI" (application 50178526) is owned by United Therapeutics Corporation.
What is the status of "TYVASO SMI"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull TYVASO SMI and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a16e04-03bd-7355-9163-6a780bf99f98
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a16e04-03bd-7355-9163-6a780bf99f98",
"object": "trademark",
"mark_text": "TYVASO SMI",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50178526",
"filing_date": "2026-10-23",
"nice_classes": [
5,
10
],
"owners": [
{
"name": "United Therapeutics Corporation",
"entity_id": "ent_01a02a6b-39a8-7144-9f55-d3b2c419290f"
}
]
}